Toxic hepatitis case with prolonged jaundice due to Favipiravir

Yolacan, RamazanKarabulut, UmitUzel, AliUcmak, FeyzullahKaya, Muhsin2024-04-242024-04-2420221307-58882757-7392https://doi.org/10.14744/hf.2022.2022.0007https://search.trdizin.gov.tr/yayin/detay/1173927https://hdl.handle.net/11468/18490Favipiravir (FPV) is an antiviral drug used in the treatment of severe acute respiratory syndrome coronavirus 2 infection. The main side effects of this drug are teratogenicity and hyperuricemia. Limited information is available on other side effects. Here, we aimed to present our toxic hepatitis case with prolonged jaundice after FPV treatment.eninfo:eu-repo/semantics/openAccessCovid-19FavipiravirJaundiceToxic HepatitisToxic hepatitis case with prolonged jaundice due to FavipiravirToxic hepatitis case with prolonged jaundice due to FavipiravirArticle339596WOS:00086355640000611739273617710210.14744/hf.2022.2022.0007N/A